Scarica l'app Stockscreener
15.08
0.66%
-0.10
Dopo l'orario di chiusura:
15.06
-0.02
-0.13%
Hutchmed China Limited Adr Borsa (HCM) Ultime notizie
ABN Amro Investment Solutions Invests $962,000 in HUTCHMED (China) Limited Sponsored ADR $HCM - Defense World
HMPL-A251 combines HER2 targeting with precision payload - BioWorld MedTech
Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing - The Globe and Mail
Transcript : HUTCHMED Limited Presents at Deutsche Bank ADR Virtual Investor Conference 2025, Nov-04-2025 08 - MarketScreener
HUTCHMED (China) Limited (HCM) HUTCHMED (China) Limited Presents at Deutsche Bank ADR Virtual Investor Conference 2025Slideshow (NASDAQ:HCM) 2025-11-04 - Seeking Alpha
Hutchmed Strengthens Position Within FTSE AIM 100 Index Healthcare Sphere - Kalkine Media
Hutchmed takes wraps off expanding oncology pipeline - Sharecast.com
Market news - investments.halifax.co.uk
RCSHutchmed China LtdUpdates from R&D Event - TradingView
HUTCHMED Highlights Pipeline and Business Progress at R&D Updates Event - The Manila Times
ETFs Investing in HUTCHMED (China) Limited Sponsored ADR Stocks - TradingView
CORRECTION -- International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 04, 2025 - The Manila Times
International companies to host live webcasts at Deutsche - GlobeNewswire
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 04, 2025 - Yahoo Finance
HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Vanguard Personalized Indexing Management LLC Buys 4,773 Shares of Cleanspark, Inc. $CLSK - Defense World
Vanguard Personalized Indexing Management LLC Boosts Stake in Knowles Corporation $KN - Defense World
Hutchmed upbeat on preclinical data for novel cancer therapy - Sharecast.com
HUTCHMED Highlights HMPL-A251 Data Presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - The Manila Times
HUTCHMED Highlights HMPL-A251 Data Presented at the - GlobeNewswire
Allianz Asset Management GmbH Sells 80,000 Shares of HUTCHMED (China) Limited Sponsored ADR $HCM - MarketBeat
Will Can Fite Biopharma Ltd Sponsored ADR stock benefit from mergersQuarterly Risk Review & Risk Controlled Stock Alerts - Trung tâm Dự báo KTTV quốc gia
Working capital per share of HUTCHMED (China) Limited Sponsored ADR – LSE:0J7G - TradingView
Pfizer: CN Biopharma Sector Shows Astonishing Growth; US Drug Industry Must Collaborate with CN - AASTOCKS.com
HUTCHMED Highlights FRUSICA-2 Registration Trial Data to be Presented at the 2025 ESMO Congress - GlobeNewswire
HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Why HUTCHMED (China) Limited (Common Stock) (H7T1) stock is favored by hedge fundsTrade Exit Report & Technical Entry and Exit Alerts - newser.com
Will HUTCHMED (China) Limited (Common Stock) (H7T1) stock deliver stable dividendsPortfolio Update Report & Verified Chart Pattern Signals - newser.com
BOCOMI: Trump's Additional Tariffs on Imported Innovative Drugs May Have Limited Actual Impact on CN Pharmas - AASTOCKS.com
HUTCHMED (NASDAQ:HCM) Shares Gap DownTime to Sell? - MarketBeat
M Stanley: Increased Recognition Pushes Biotech Stocks to Outpace Mkt - AASTOCKS.com
Best Momentum Stock to Buy for August 19th - MSN
National Research Corporation $NRC Shares Sold by Goldman Sachs Group Inc. - Defense World
HUTCHMED (China) Limited Sponsored ADR $HCM Stock Position Raised by Goldman Sachs Group Inc. - Defense World
HUTCHMED (NASDAQ:HCM) Shares Gap UpHere's What Happened - MarketBeat
HUTCHMED (NASDAQ:HCM) Shares Gap Up – Should You Buy? - Defense World
Price action breakdown for HUTCHMED (China) Limited Depositary Receipt2025 Dividend Review & Risk Managed Investment Strategies - newser.com
Top Blockchain Stocks To Follow Now – September 12th - Defense World
HSBC Research Positive on LT Growth of CN Biotech, Favors INNOVENT BIO/ HANSOH PHARMA - AASTOCKS.com
G Sachs Gives ST Risk Analysis for 3 Types of Firms as US Reportedly Planning to Tighten Scrutiny on CN Innovative Drugs Could Pose 'Headline Risks' for CN Pharmas - AASTOCKS.com
CN SASAC Advocates to Accelerate Development of Central SOEs in the Biopharmaceutical Industry, Build National Team in Such Field - AASTOCKS.com
Intraday pattern recognizer results for HUTCHMED (China) Limited Depositary Receipt2025 Biggest Moves & Trade Opportunity Analysis Reports - Newser
Combining machine learning predictions for HUTCHMED (China) Limited Depositary ReceiptQuarterly Market Review & Verified Entry Point Signals - Newser
How moving averages guide HUTCHMED (China) Limited Depositary Receipt trading2025 Retail Activity & Stepwise Trade Signal Implementation - Newser
HUTCHMED Announces Appointment of Acting Chief Executive Officer - GlobeNewswire Inc.
Solventum Corporation $SOLV Shares Sold by Russell Investments Group Ltd. - Defense World
HUTCHMED Completes Patient Enrollment of SANOVO Phase III Trial of ORPATHYS® and TAGRISSO® Combination as a First-Line Therapy for Certain Lung Cancer Patients in China - GlobeNewswire
Best Momentum Stock To Buy For August 19th - Barchart.com
2.58%
4.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):